Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (21) Chen, Wei Prof. Dr. (2) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (2) Fälber, Katja Dr. (1) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Kammertöns, Thomas Dr. (4) Kieback, Elisa Dr. (2) Kirchner, Marieluise Dr. (1) Klußmann, Enno PD Dr. (1) Kopp, Joachim Dr. (2) Lewin, Gary Prof. Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (2) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (21) Wanker, Erich Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zauber, Henrik Dr. (3) Zühlke, Kerstin Dr. (1) (-) Bunse, Mario Dr. (1) (-) Landthaler, Markus Prof. Dr. (3) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Uckert, Wolfgang Prof. Dr. (6) (-) Willimsky, Gerald Dr. (7) (-) Wyler, Emanuel Dr. (1) Bioinformatik der Genregulation (2) Experimentelle Ultrahochfeld-MR (6) Genetik metabolischer und reproduktiver Störungen (3) Genom-Editierung & Krankheitsmodelle (2) Genomics (1) Immunregulation und Krebs (3) Magnetic Resonance (6) Mobile DNA (2) (-) Molekulare Immunologie und Gentherapie (13) Nicht-Kodierende RNAs und Mechanismen der Genregulation im Cytoplasma (1) (-) Proteom Dynamik (3) RNA Biologie und Posttranscriptionale Regulation (11) Systembiologie von Gen-regulatorischen Elementen (2) Transgenics (2) Translationale Onkologie solider Tumore (1) Zelluläre Neurowissenschaften (5) 1997 (1) 1998 (1) 2000 (3) 2002 (1) 2003 (4) 2004 (1) 2005 (7) 2006 (1) 2007 (4) (-) 2008 (3) (-) 2010 (5) (-) 2011 (4) 2012 (1) 2013 (5) 2014 (2) 2015 (4) (-) 2016 (4) 2017 (3) 2018 (6) 2019 (2) 2020 (2) 2021 (4) 2022 (7) 2023 (2) 16 Ergebnisse: Active Filter: Bunse, Mario Dr.Landthaler, Markus Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Uckert, Wolfgang Prof. Dr.Willimsky, Gerald Dr.Wyler, Emanuel Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik2008201020112016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. März 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein 05. August 2011 / Mol Cell Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR S. Lebedeva M. Jens K. Theil B. Schwanhaeusser M. Selbach M. Landthaler N. Rajewsky 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. September 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. März 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein
05. August 2011 / Mol Cell Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR S. Lebedeva M. Jens K. Theil B. Schwanhaeusser M. Selbach M. Landthaler N. Rajewsky
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. September 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
16. Dezember 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein